Blocking fatty ceramides could stop acute kidney injury—and possibly revolutionize mitochondrial disease treatment.

These findings underscore the limitations of relying on proteinuria alone to assess LN treatment success and demonstrate the clinical utility of biomarker-guided risk stratification.

Kidney stone pain can radiate from the back or side to the lower abdomen or groin, whereas menstrual cramps cause discomfort ...